tiprankstipranks
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market
SNTI
Senti Biosciences
RESEARCH TOOLSreports
Want to see SNTI full AI Analyst Report?

Senti Biosciences (SNTI) Stock News & Sentiment

254 Followers
Senti Biosciences Faces Severe Refinancing and Liquidity Risks from Costly Note Structure
Premium
Company Announcements
Senti Biosciences Faces Severe Refinancing and Liquidity Risks from Costly Note Structure
3d ago
SNTI
Analyst Maintains Buy on Senti Biosciences, Keeps $12 Price Target on Strengthened Clinical, Regulatory, and Financial Position
Premium
Ratings
Analyst Maintains Buy on Senti Biosciences, Keeps $12 Price Target on Strengthened Clinical, Regulatory, and Financial Position
4d ago
SNTI
Senti Biosciences Advances SENTI-202 With New FDA Support
Premium
Company Announcements
Senti Biosciences Advances SENTI-202 With New FDA Support
5d ago
8K
SNTI
Senti Biosciences Secures Convertible Note Financing with Celadon
Premium
Company Announcements
Senti Biosciences Secures Convertible Note Financing with Celadon
18d ago
8K
SNTI
Senti Biosciences Plans Tax-Free Holding Company Reorganization
Premium
Company Announcements
Senti Biosciences Plans Tax-Free Holding Company Reorganization
2M ago
8K
SNTI
Buy Rating on SENTI-202 Driven by Strong Early AML Efficacy and De-Risking Regulatory Designations Despite Financing Overhang
Premium
Ratings
Buy Rating on SENTI-202 Driven by Strong Early AML Efficacy and De-Risking Regulatory Designations Despite Financing Overhang
2M ago
SNTI
Senti Biosciences Amends Lease, Restructures GeneFab Sublease
Premium
Company Announcements
Senti Biosciences Amends Lease, Restructures GeneFab Sublease
2M ago
8K
SNTI
More SNTI News >

SNTI News on the Web

Analysts Conflicted on These Healthcare Names: Senti Biosciences (SNTI), ALX Oncology Holdings (ALXO) and Argenx Se (ARGX)
TipRanks News
Bullish
Senti Biosciences Faces Severe Refinancing and Liquidity Risks from Costly Note Structure
TipRanks News
Bearish
Analyst Maintains Buy on Senti Biosciences, Keeps $12 Price Target on Strengthened Clinical, Regulatory, and Financial Position
TipRanks News
Bullish
Senti Bio completes Type B RMAT meeting with FDA on SENTI-202
TipRanks News
Bullish
Senti Bio reports Q1 EPS (14c), consensus (36c)
TipRanks News
Bullish
Senti Biosciences Advances SENTI-202 With New FDA Support
TipRanks News
Neutral
Senti Biosciences Secures Convertible Note Financing with Celadon
TipRanks News
Bearish
Senti Biosciences Plans Tax-Free Holding Company Reorganization
TipRanks News
Bearish

News Score - Last 7 Days

Positive
SNTI
Sector Average
Media Buzz
This Week7 articles
Weekly Average0.25 articles
News Sentiment
This Week67%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SNTI’s Media Buzz Sentiment?
7 articles about SNTI were published this week. In an average week, 0.25 articles are published.
    What is SNTI’s weekly average amount of articles?
    In an average week, 0.25 articles about SNTI are published.
      What is SNTI’s News Sentiment?
      67% of articles about SNTI were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        AQSTAquestive Therapeutics
        GOSSGossamer Bio
        HTFLHeartFlow, Inc.
        Showing the stocks with the most bullish news sentiment over the past week